|
|
|
|
|
|
|
Amicus Therapeutics (FOLD)
|
|
14.21 -0.43 (-2.94%)
|
04-20 16:00
|
|
Open:
|
14.47
|
Pre. Close:
|
14.64
|
|
High:
|
14.82
|
Low:
|
14.16
|
|
Volume:
|
1,606,983
|
Market Cap:
|
2671M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
14.835 - 14.916
|
14.916 - 14.983
|
|
Low:
|
13.967 - 14.066
|
14.066 - 14.149
|
|
Close:
|
14.061 - 14.212
|
14.212 - 14.337
|
|
|
|
Technical analysis (as of: 2018-04-20 4:29:52 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 17.85 One year: 20.85
|
|
Support:
|
Support1: 13.56 Support2: 12.50
|
|
Resistance:
|
Resistance1:
15.28 Resistance2: 17.85
|
|
Pivot:
|
14.14
|
|
Moving Averages:
|
MA(5): 14.55 MA(20): 14.24 
MA(100): 14.63 MA(250): 12.96
|
|
MACD:
|
MACD(12,26):
-0.02 Signal(12,26,9): -0.10
|
|
%K %D:
|
%K(14,3): 75.14 %D(3): 77.29
|
|
RSI:
|
RSI(14): 47.57
|
|
52-Week:
|
High: 17.4
Low: 6.41 Change(%): 90.7
|
|
Average Vol(K):
|
3-Month: 309130
10-Days 191479
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.FOLD has closed below upper band by 47.1%. Bollinger Bands are 3.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-04-15T00:25:16-04:00
Portfolio Review: Continued Market Outperformance In Q1 2018
2018-03-19T15:44:47-04:00
Protalix: A Definite Sell - No Prize For The Fourth Runner Up
2018-03-16T15:12:03-04:00
Amicus Therapeutics (FOLD) Presents At Barclays Global Healthcare Conference 2018 - Slideshow
2018-03-09T16:24:55-05:00
Daily Insider Ratings Round Up 3/7/18: FOLD, ATT, CHN, EPD, GTE, CLR
2018-03-07T18:35:48-05:00
Daily Insider Ratings Roundup For March 6, 2018: FOLD, RDUS, BW, AXDX, TMUS, GKOS, And BOMN
2018-03-01T12:05:10-05:00
ROTY Volume 1 Edition 83: Thank You For Your Patience - Launch Day Has Arrived!
2018-02-28T12:00:51-05:00
Amicus Therapeutics' (FOLD) CEO John Crowley on Q4 2017 Results - Earnings Call Transcript
2018-02-28T08:33:35-05:00
Amicus Therapeutics, Inc. 2017 Q4 - Results - Earnings Call Slides
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
